Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) insider Andrew Gengos bought 45,000 shares of Athira Pharma stock in a transaction dated Monday, June 5th. The shares were purchased at an average cost of $3.00 per share, for a total transaction of $135,000.00. Following the completion of the transaction, the insider now owns 65,012 shares of […]